Book Your Appointment

Contact Us

Please select the service category that you're looking to book an appointment for:

We're currently accepting appointments in the following areas. Please email hello@directcare.us if you would like to schedule a test nationally.

If you opt for a home visit, we'll send a healthcare professional to your home at the scheduled time, and you can choose whether to do your appointment inside or outside, provided that the space is well lit, and you have a comfortable seating area.

QUESTIONS?

Contact Us

Which tests are offered through our partner labs?

Covid-19  Laboratory Developed PCR Test

Thermo Fisher and Ortho Clinical are listed on the FDA Emergency Use Authorization at the FDA website, under FAQs on Diagnostic Testing for SARS-CoV-2.

All swab tests have high sensitivity and high specificity.

SARS-CoV-2 (COVID-19) Antibody, IgG and IgM Tests

Roche and BD are performing the SARS-CoV-2 Antibody, IgG and IgM Tests in combination. Below is some background information on this testing.

After infection with SARS-CoV-2, viral antigens stimulate the body’s immune system to produce antibodies.  The virus incubation period and the days/weeks when the antibodies appear in the blood are defined below.

SARS-CoV-2 virus Antibodies, IgM and IgG

  • IgM appears early in the blood circulation after an infection (as early as 3-5 days).  
  • IgG appears later  in the blood circulation after an infection (within 3-4 weeks).

"The IgM and IgG tests are able to detect the antibodies to the SARS-CoV-2 virus and the kits have high specificity, sensitivity and clinical agreement with samples confirmed with PCR methods (RT-qPCR)".

Regulatory Statements

COVID-19 Antibody Test

The CLIA lab validated diagnostic tests being offered by this site are in accordance with the FDA’s Emergency Use Notification and Authorization process as provided in the FDA’s “Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency” (March 16, 2020) for laboratories certified under CLIA and FDA standards to perform high-complexity testing.  Our test’s manufacturing lab has notified the FDA as required and has been listed on the FDA’s website accordingly.

  • This test has not been reviewed by the FDA.
  • Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals.
  • Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.
  • Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.
  • This test is not for the screening of donated blood

COVID-19 PCR Swab Test

The CLIA lab validated diagnostic tests being offered by this site are in accordance with the FDA’s Emergency Use Notification and Authorization process as provided in the FDA’s “Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency” (March 16, 2020) for laboratories certified under CLIA and FDA standards to perform high-complexity testing.  Our test’s manufacturing lab has notified the FDA as required and has been listed on the FDA’s website accordingly and received FDA authorization.